Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Review article: Biomedical intelligence

Vol. 153 No. 2 (2023)

Immediate and delayed hypersensitivity reactions to corticosteroids – prevalence, diagnosis and treatment

  • Keren Mahlab-Guri
  • Ilan Asher
  • Zev Sthoeger
DOI
https://doi.org/10.57187/smw.2023.40025
Cite this as:
Swiss Med Wkly. 2023;153:40025
Published
20.02.2023

Summary

BACKGROUND: Corticosteroids, which are anti-inflammatory and immunosuppressive agents used for the treatment of various diseases including allergic disorders, can induce immediate and delayed hypersensitivity reactions. Although these reactions are not common, due to the wide usage of corticosteroid medications, corticosteroid hypersensitivity reactions are clinically important.

OBJECTIVE: In this review, we summarise the prevalence, pathogenetic mechanism, clinical manifestations, risk factors, diagnostic and therapeutic approach for corticosteroid-induced hypersensitivity reactions.

METHODS: An integrative review of the literature was conducted using PubMed searches (mainly large cohort-based studies) regarding the different aspects of corticosteroid hypersensitivity.

RESULTS: Hypersensitivity reactions to corticosteroids can be immediate or delayed and can follow all modes of corticosteroid administration. Prick and intradermal skin tests are useful diagnostic tools for immediate hypersensitivity reactions, patch tests are useful for delayed hypersensitivity reactions. According to the diagnostic tests an alternative (safe) corticosteroid agent should be administered.

CONCLUSION: Physicians of all medical disciplines should be aware that corticosteroids can cause (“paradoxically”) immediate or delayed allergic hypersensitivity reactions. The diagnosis of such allergic reactions is challenging since it is often difficult to distinguish between hypersensitivity reactions and deterioration of the basic inflammatory disease (e.g., worsening of asthma or dermatitis). Thus, a high index of suspicion is needed in order to identify the culprit corticosteroid. 

References

  1. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids—new mechanisms for old drugs. N Engl J Med. 2005 Oct;353(16):1711–23. https://doi.org/10.1056/NEJMra050541 DOI: https://doi.org/10.1056/NEJMra050541
  2. Strehl C, Ehlers L, Gaber T, Buttgereit F. Glucocorticoids-All-Rounders Tackling the Versatile Players of the Immune System. Front Immunol. 2019 Jul;10:1744. https://doi.org/10.3389/fimmu.2019.01744 DOI: https://doi.org/10.3389/fimmu.2019.01744
  3. Coopman S, Degreef H, Dooms-Goossens A. Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids. Br J Dermatol. 1989 Jul;121(1):27–34. https://doi.org/10.1111/j.1365-2133.1989.tb01396.x DOI: https://doi.org/10.1111/j.1365-2133.1989.tb01396.x
  4. Goossens A, Matura M, Degreef H. Reactions to corticosteroids: some new aspects regarding cross-sensitivity. Cutis. 2000 Jan;65(1):43–5.
  5. Matura M, Goossens A, Matura M. Contact allergy to corticosteroids. Allergy. 2000 Aug;55(8):698–704. https://doi.org/10.1034/j.1398-9995.2000.00121.x DOI: https://doi.org/10.1034/j.1398-9995.2000.00121.x
  6. Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013 Aug;9(1):30. https://doi.org/10.1186/1710-1492-9-30 DOI: https://doi.org/10.1186/1710-1492-9-30
  7. Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, et al. Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes. Eur Respir J. 2021 Dec;59(1):59. DOI: https://doi.org/10.1183/13993003.02730-2021
  8. Vatti RR, Ali F, Teuber S, Chang C, Gershwin ME. Hypersensitivity reactions to corticosteroids. Clin Rev Allergy Immunol. 2014 Aug;47(1):26–37. https://doi.org/10.1007/s12016-013-8365-z DOI: https://doi.org/10.1007/s12016-013-8365-z
  9. Rodrigo C, Alejandro C, Javier H, et al. Hypersensivity Reactions to Steroids [Review]. Glob Vaccines Immunol. 2018;3. DOI: https://doi.org/10.15761/GVI.1000129
  10. Baeck M, Goossens A. Immediate and delayed allergic hypersensitivity to corticosteroids: practical guidelines. Contact Dermat. 2012 Jan;66(1):38–45. https://doi.org/10.1111/j.1600-0536.2011.01967.x DOI: https://doi.org/10.1111/j.1600-0536.2011.01967.x
  11. Otani IM, Banerji A. Immediate and Delayed Hypersensitivity Reactions to Corticosteroids: evaluation and Management. Curr Allergy Asthma Rep. 2016 Mar;16(3):18. https://doi.org/10.1007/s11882-016-0596-7 DOI: https://doi.org/10.1007/s11882-016-0596-7
  12. Baeck M, Marot L, Nicolas JF, Pilette C, Tennstedt D, Goossens A. Allergic hypersensitivity to topical and systemic corticosteroids: a review. Allergy. 2009 Jul;64(7):978–94. https://doi.org/10.1111/j.1398-9995.2009.02038.x DOI: https://doi.org/10.1111/j.1398-9995.2009.02038.x
  13. Klein-Gitelman MS, Pachman LM. Intravenous corticosteroids: adverse reactions are more variable than expected in children. J Rheumatol. 1998 Oct;25(10):1995–2002.
  14. Borja JM, Galindo PA, Feo F, Gomez E. Urticaria to methylprednisolone sodium hemisuccinate. Allergy. 2001 Aug;56(8):791. https://doi.org/10.1034/j.1398-9995.2001.056008791.x DOI: https://doi.org/10.1034/j.1398-9995.2001.056008791.x
  15. Isaksson M, Bruze M. Corticosteroids. Dermatitis. 2005 Mar;16(1):3–5. DOI: https://doi.org/10.1097/01206501-200503000-00002
  16. Ventura MT, Calogiuri GF, Muratore L, Di Leo E, Buquicchio R, Ferrannini A, et al. Cross-reactivity in cell-mediated and IgE-mediated hypersensitivity to glucocorticoids. Curr Pharm Des. 2006;12(26):3383–91. https://doi.org/10.2174/138161206778194006 DOI: https://doi.org/10.2174/138161206778194006
  17. Vind-Kezunovic D, Johansen JD, Carlsen BC. Prevalence of and factors influencing sensitization to corticosteroids in a Danish patch test population. Contact Dermat. 2011 Jun;64(6):325–9. https://doi.org/10.1111/j.1600-0536.2011.01898.x DOI: https://doi.org/10.1111/j.1600-0536.2011.01898.x
  18. Venturini M, Lobera T, del Pozo MD, González I, Blasco A. Immediate hypersensitivity to corticosteroids. J Investig Allergol Clin Immunol. 2006;16(1):51–6.
  19. Baeck M, Chemelle JA, Terreux R, Drieghe J, Goossens A. Delayed hypersensitivity to corticosteroids in a series of 315 patients: clinical data and patch test results. Contact Dermat. 2009 Sep;61(3):163–75. https://doi.org/10.1111/j.1600-0536.2009.01602.x DOI: https://doi.org/10.1111/j.1600-0536.2009.01602.x
  20. Baker A, Empson M, The R, Fitzharris P. Skin testing for immediate hypersensitivity to corticosteroids: a case series and literature review. Clin Exp Allergy. 2015 Mar;45(3):669–76. https://doi.org/10.1111/cea.12441 DOI: https://doi.org/10.1111/cea.12441
  21. Voltolini S, Fumagalli F. Delayed corticosteroid hypersensitivity: a clinical management proposal. Eur Ann Allergy Clin Immunol. 2021 Jul;53(4):171–6. https://doi.org/10.23822/EurAnnACI.1764-1489.164 DOI: https://doi.org/10.23822/EurAnnACI.1764-1489.164
  22. Krasowski MD, Drees D, Morris CS, Maakestad J, Blau JL, Ekins S. Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction. BMC Clin Pathol. 2014 Jul;14(1):33. https://doi.org/10.1186/1472-6890-14-33 DOI: https://doi.org/10.1186/1472-6890-14-33
  23. Baeck M, Chemelle JA, Goossens A, Nicolas JF, Terreux R. Corticosteroid cross-reactivity: clinical and molecular modelling tools. Allergy. 2011 Oct;66(10):1367–74. https://doi.org/10.1111/j.1398-9995.2011.02666.x DOI: https://doi.org/10.1111/j.1398-9995.2011.02666.x
  24. de Sousa NG, Santa-Marta C, Morais-Almeida M. Systemic corticosteroid hypersensitivity in children. J Investig Allergol Clin Immunol. 2010;20(6):529–32.
  25. Cheam H, Butani L. Immunoglobulin E-mediated reactions to corticosteroids. Curr Allergy Asthma Rep. 2005 Jan;5(1):22–7. https://doi.org/10.1007/s11882-005-0050-8 DOI: https://doi.org/10.1007/s11882-005-0050-8
  26. Kamm GL, Hagmeyer KO. Allergic-type reactions to corticosteroids. Ann Pharmacother. 1999 Apr;33(4):451–60. https://doi.org/10.1345/aph.18276 DOI: https://doi.org/10.1345/aph.18276
  27. Rachid R, Leslie D, Schneider L, Twarog F. Hypersensitivity to systemic corticosteroids: an infrequent but potentially life-threatening condition. J Allergy Clin Immunol. 2011 Feb;127(2):524–8. https://doi.org/10.1016/j.jaci.2010.09.030 DOI: https://doi.org/10.1016/j.jaci.2010.09.030
  28. Ventura MT, Calogiuri GF, Matino MG, Dagnello M, Buquicchio R, Foti C, et al. Alternative glucocorticoids for use in cases of adverse reaction to systemic glucocorticoids: a study on 10 patients. Br J Dermatol. 2003 Jan;148(1):139–41. https://doi.org/10.1046/j.1365-2133.2003.05061.x DOI: https://doi.org/10.1046/j.1365-2133.2003.05061.x
  29. Patel A, Bahna SL. Immediate hypersensitivity reactions to corticosteroids. Ann Allergy Asthma Immunol. 2015 Sep;115(3):178–182.e3. https://doi.org/10.1016/j.anai.2015.06.022 DOI: https://doi.org/10.1016/j.anai.2015.06.022
  30. Burgdorff T, Venemalm L, Vogt T, Landthaler M, Stolz W. IgE-mediated anaphylactic reaction induced by succinate ester of methylprednisolone. Ann Allergy Asthma Immunol. 2002 Oct;89(4):425–8. https://doi.org/10.1016/S1081-1206(10)62046-7 DOI: https://doi.org/10.1016/S1081-1206(10)62046-7
  31. Isaksson M, Beck MH, Wilkinson SM. Comparative testing with budesonide in petrolatum and ethanol in a standard series. Contact Dermat. 2002 Aug;47(2):123–4. https://doi.org/10.1034/j.1600-0536.2002.470210_16.x DOI: https://doi.org/10.1034/j.1600-0536.2002.470210_16.x
  32. Lauerma AI. Screening for corticosteroid contact sensitivity. Comparison of tixocortol pivalate, hydrocortisone-17-butyrate and hydrocortisone. Contact Dermat. 1991 Feb;24(2):123–30. https://doi.org/10.1111/j.1600-0536.1991.tb01664.x DOI: https://doi.org/10.1111/j.1600-0536.1991.tb01664.x
  33. Ben Said B, Leray V, Nicolas JF, Rozieres A, Berard F. Methylprednisolone-induced anaphylaxis: diagnosis by skin test and basophil activation test. Allergy. 2010 Apr;65(4):531–2. https://doi.org/10.1111/j.1398-9995.2009.02199.x DOI: https://doi.org/10.1111/j.1398-9995.2009.02199.x
  34. Muraro A, Worm M, Alviani C, Cardona V, DunnGalvin A, Garvey LH, et al.; European Academy of Allergy and Clinical Immunology, Food Allergy, Anaphylaxis Guidelines Group. EAACI guidelines: Anaphylaxis (2021 update). Allergy. 2022 Feb;77(2):357–77. https://doi.org/10.1111/all.15032 DOI: https://doi.org/10.1111/all.15032
  35. Solensky R. Drug desensitization [vi.]. Immunol Allergy Clin North Am. 2004 Aug;24(3):425–43. https://doi.org/10.1016/j.iac.2004.03.008 DOI: https://doi.org/10.1016/j.iac.2004.03.008
  36. Angel-Pereira D, Berges-Gimeno MP, Madrigal-Burgaleta R, Ureña-Tavera MA, Zamora-Verduga M, Alvarez-Cuesta E. Successful rapid desensitization to methylprednisolone sodium hemisuccinate: a case report. J Allergy Clin Immunol Pract. 2014;2(3):346–8. https://doi.org/10.1016/j.jaip.2013.12.011 DOI: https://doi.org/10.1016/j.jaip.2013.12.011
  37. Burden AD, Beck MH. Contact hypersensitivity to topical corticosteroids. Br J Dermatol. 1992 Nov;127(5):497–500. https://doi.org/10.1111/j.1365-2133.1992.tb14847.x DOI: https://doi.org/10.1111/j.1365-2133.1992.tb14847.x
  38. Soria A, Baeck M, Goossens A, Marot L, Duveille V, Derouaux AS, et al. Patch, prick or intradermal tests to detect delayed hypersensitivity to corticosteroids? Contact Dermat. 2011 Jun;64(6):313–24. https://doi.org/10.1111/j.1600-0536.2011.01888.x DOI: https://doi.org/10.1111/j.1600-0536.2011.01888.x
  39. Baeck M, Goossens A. Systemic contact dermatitis to corticosteroids. Allergy. 2012 Dec;67(12):1580–5. DOI: https://doi.org/10.1111/all.12041
  40. Baeck M, Pilette C, Drieghe J, Goossens A. Allergic contact dermatitis to inhalation corticosteroids. Eur J Dermatol. 2010;20(1):102–8. https://doi.org/10.1684/ejd.2010.0826 DOI: https://doi.org/10.1684/ejd.2010.0826
  41. Cadinha S, Malheiro D, Rodrigues J, Castro E, Castel-Branco MG. Delayed hypersensitivity reactions to corticosteroids. Allergol Immunopathol (Madr). 2005;33(6):329–32. https://doi.org/10.1016/S0301-0546(05)73252-3 DOI: https://doi.org/10.1016/S0301-0546(05)73252-3
  42. Santos-Alarcón S, Benavente-Villegas FC, Farzanegan-Miñano R, Pérez-Francés C, Sánchez-Motilla JM, Mateu-Puchades A. Delayed hypersensitivity to topical and systemic corticosteroids. Contact Dermat. 2018 Jan;78(1):86–8. https://doi.org/10.1111/cod.12841 DOI: https://doi.org/10.1111/cod.12841
  43. Reitamo S, Lauerma AI, Stubb S, Käyhkö K, Visa K, Förström L. Delayed hypersensitivity to topical corticosteroids. J Am Acad Dermatol. 1986 Apr;14(4):582–9. https://doi.org/10.1016/S0190-9622(86)70073-X DOI: https://doi.org/10.1016/S0190-9622(86)70073-X
  44. Gönül M, Gül U. Detection of contact hypersensitivity to corticosteroids in allergic contact dermatitis patients who do not respond to topical corticosteroids. Contact Dermat. 2005 Aug;53(2):67–70. https://doi.org/10.1111/j.0105-1873.2005.00638.x DOI: https://doi.org/10.1111/j.0105-1873.2005.00638.x
  45. Pratt MD, Mufti A, Lipson J, Warshaw EM, Maibach HI, Taylor JS, et al. Patch Test Reactions to Corticosteroids: Retrospective Analysis From the North American Contact Dermatitis Group 2007-2014. Dermatitis. 2017;28(1):58–63. https://doi.org/10.1097/DER.0000000000000251 DOI: https://doi.org/10.1097/DER.0000000000000251
  46. Isaksson M, Brandão FM, Bruze M, Goossens A; European Society of Contact Dermatitis. Recommendation to include budesonide and tixocortol pivalate in the European standard series. ESCD and EECDRG. Contact Dermat. 2000 Jul;43(1):41–2.